---
title: "20/20 Biolabs, Inc. 1Q 2026: Revenue $353.38K, EPS ($0.28) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287114082.md"
description: "20/20 Biolabs, Inc. reported a revenue decline to $353.38K in Q1 2026, with a net loss of $2.12M and diluted EPS of ($0.28), compared to ($0.16) a year ago. The drop in revenue was attributed to lower OneTest and BioCheck sales, and a major OneTest renewal was delayed. The company launched OneTest for Longevity and increased R&D spending to support its product pipeline."
datetime: "2026-05-20T20:21:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287114082.md)
  - [en](https://longbridge.com/en/news/287114082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287114082.md)
---

# 20/20 Biolabs, Inc. 1Q 2026: Revenue $353.38K, EPS ($0.28) — 10-Q Summary

20/20 Biolabs, Inc. reported first-quarter 2026 results marked by a revenue decline to $353.38K and a widened net loss, with diluted EPS of ($0.28) versus ($0.16) in the year-ago quarter.

**Financial Highlights**

Metric

Current quarter

Prior year quarter

YoY change

Revenue¹

$353.38K

$553.82K

(36.2%)

Net income²

($2.12M)

($764.58K)

(177.4%)

Diluted EPS³

($0.28)

($0.16)

(75%)

_¹ Reported as “Revenues”. ² Reported as “Net loss attributable to common stockholders”. ³ Reported as “loss per common share”._

**Business Highlights**

-   Revenue decline driven by lower OneTest and BioCheck sales year over year.
-   Timing of a major OneTest renewal shifted into Q2 after a fire department customer delayed renewal, reducing quarter bookings.
-   Launched OneTest for Longevity in February 2026 and rebranded offerings for workplace wellness to target employers.
-   Continued operation of the company’s CAP/CLIA lab and the CLIAx shared-lab service for overseas startups.
-   Increased R&D spending to develop and validate the Longevity test, supporting the product pipeline.

Original SEC Filing: 20/20 Biolabs, Inc. \[ AIDX \] - 10-Q - May. 20, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AIDX.US](https://longbridge.com/en/quote/AIDX.US.md)

## Related News & Research

- [AleAnna, Inc. Reports First Quarter 2026 Results | ANNA Stock News](https://longbridge.com/en/news/286463118.md)
- [Capstone Companies, Inc. announces Execution of Binding Letter of Intent with eBliss Global, Inc. | CAPC Stock News](https://longbridge.com/en/news/286782166.md)
- [OceanPal Inc. Announces 2026 Annual General Meeting of Shareholders to be Held on June 16, 2026 | SVRN Stock News](https://longbridge.com/en/news/286308382.md)
- [COSCIENS Biopharma Inc. Reports Q1 2026 Results | CSCIF Stock News](https://longbridge.com/en/news/286158199.md)
- [Dana Investment Advisors Inc. Sells 18,459 Shares of Fortinet, Inc. $FTNT](https://longbridge.com/en/news/287023545.md)